BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30476545)

  • 1. CXCR6 protects from inflammation and fibrosis in NEMO
    Liepelt A; Wehr A; Kohlhepp M; Mossanen JC; Kreggenwinkel K; Denecke B; Costa IG; Luedde T; Trautwein C; Tacke F
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):391-402. PubMed ID: 30476545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion.
    Bartneck M; Koppe C; Fech V; Warzecha KT; Kohlhepp M; Huss S; Weiskirchen R; Trautwein C; Luedde T; Tacke F
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):327-347. PubMed ID: 32896623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
    Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
    J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
    Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
    Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
    Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
    Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
    Beraza N; Malato Y; Sander LE; Al-Masaoudi M; Freimuth J; Riethmacher D; Gores GJ; Roskams T; Liedtke C; Trautwein C
    J Exp Med; 2009 Aug; 206(8):1727-37. PubMed ID: 19635861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
    Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
    Beraza N; Ofner-Ziegenfuss L; Ehedego H; Boekschoten M; Bischoff SC; Mueller M; Trauner M; Trautwein C
    Gut; 2011 Mar; 60(3):387-96. PubMed ID: 21115542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration.
    Koppe C; Reisinger F; Wehr K; Vucur M; Trautwein C; Tacke F; Heikenwalder M; Luedde T
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31319593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.
    Luedde T; Beraza N; Kotsikoris V; van Loo G; Nenci A; De Vos R; Roskams T; Trautwein C; Pasparakis M
    Cancer Cell; 2007 Feb; 11(2):119-32. PubMed ID: 17292824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
    Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
    J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIPK1 protects from TNF-α-mediated liver damage during hepatitis.
    Filliol A; Piquet-Pellorce C; Le Seyec J; Farooq M; Genet V; Lucas-Clerc C; Bertin J; Gough PJ; Dimanche-Boitrel MT; Vandenabeele P; Bertrand MJ; Samson M
    Cell Death Dis; 2016 Nov; 7(11):e2462. PubMed ID: 27831558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury.
    Liedtke C; Bangen JM; Freimuth J; Beraza N; Lambertz D; Cubero FJ; Hatting M; Karlmark KR; Streetz KL; Krombach GA; Tacke F; Gassler N; Riethmacher D; Trautwein C
    Gastroenterology; 2011 Dec; 141(6):2176-87. PubMed ID: 21878202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB essential modifier is required for hepatocyte proliferation and the oval cell reaction after partial hepatectomy in mice.
    Malato Y; Ehedego H; Al-Masaoudi M; Cubero FJ; Bornemann J; Gassler N; Liedtke C; Beraza N; Trautwein C
    Gastroenterology; 2012 Dec; 143(6):1597-1608.e11. PubMed ID: 22922425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial NEMO/IKKγ limits fibrosis and promotes regeneration during pancreatitis.
    Chan LK; Gerstenlauer M; Konukiewitz B; Steiger K; Weichert W; Wirth T; Maier HJ
    Gut; 2017 Nov; 66(11):1995-2007. PubMed ID: 27464707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
    Zhu H; Zhang Q; Chen G
    Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the FasL/Fas axis protects against inflammation-derived tumorigenesis in chronic liver disease.
    Cubero FJ; Woitok MM; Zoubek ME; de Bruin A; Hatting M; Trautwein C
    Cell Death Dis; 2019 Feb; 10(2):115. PubMed ID: 30737368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis.
    Ehedego H; Boekschoten MV; Hu W; Doler C; Haybaeck J; Gaβler N; Müller M; Liedtke C; Trautwein C
    Cancer Res; 2015 Mar; 75(6):1144-55. PubMed ID: 25608711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DJ-1 deficiency attenuates expansion of liver progenitor cells through modulating the inflammatory and fibrogenic niches.
    Chen L; Luo M; Sun X; Qin J; Yu C; Wen Y; Zhang Q; Gu J; Xia Q; Kong X
    Cell Death Dis; 2016 Jun; 7(6):e2257. PubMed ID: 27277679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.